This Article Full Text Full Text (PDF) All Versions of this Article: 39/2/286    most recent STROKEAHA.107.511857v1 Alert me when this article is cited Alert me if a correction is posted Citation Map Services Email this article to a friend Similar articles in this journal Similar articles in PubMed Alert me to new issues of the journal Download to citation manager Request Permissions Citing Articles Citing Articles via Google Scholar Google Scholar Articles by Harraz, M. M. Articles by Dawson, V. L. Search for Related Content PubMed PubMed Citation Articles by Harraz, M. M. Articles by Dawson, V. L. Related Collections Pathophysiology

(Stroke. 2008;39:286.)
© 2008 American Heart Association, Inc.

Advances in Stroke 2007

Advances in Neuronal Cell Death 2007

From the Institute for Cell Engineering (M.M.H., T.M.D., V.L.D.), Departments of Neurology (M.M.H., T.M.D., V.L.D.), Neuroscience (T.M.D., V.L.D.), and Physiology (V.L.D.), The Johns Hopkins University School of Medicine, Baltimore, Md, USA.

Correspondence to Valina L. Dawson, PhD, Institute for Cell Engineering, Johns Hopkins University School of Medicine, 733 North Broadway, Suite 731, Baltimore, MD 21205, USA. E-mail vdawson@jhmi.edu

Key Words: apoptosis • cell death

An extract of the first 250 words of the full text is provided, because this article has no abstract.

In a stroke lesion, there is a core of necrotic cell death surrounded by a zone of tissue at risk, termed the penumbra. In the penumbra, there is usually less severe tissue damage. Programmed cell death (PCD) pathways have been documented to be present in the penumbra. While many studies have used the term apoptosis as equivalent to PCD, the absence of complete biochemical and morphological characteristics of apoptosis, coupled with the ineffectiveness of caspase inhibitors, indicates that there are other important cell death pathways activated during stroke. A few caspase-independent cell death pathways have been identified and there are likely more to be described.

Parthanatos

Stroke injury leads to the activation of a cell death program, dependent on poly(ADP-ribose) polymerase-1 (PARP1) activation¹ and culminating in apoptosis inducing factor (AIF) mediated cell death.² Poly(ADP-ribose) (PAR) polymer is the death signal in this pathway and Thanatos is the Greek personification of death and mortality, hence, the name parthanatos. In this form of cell death that occurs in many different organ systems during ischemia-reperfusion injury, PAR polymer translocates from the nucleus to the cytoplasm and mitochondria. This leads to release of AIF from the mitochondria, an effect that is inhibited by poly(ADP-ribose) glycohydrolase (PARG), an enzyme that degrades PAR polymer.³ After cerebral focal ischemia reperfusion injury, mice with reduced PARG levels had higher infarct volumes than controls. On the other hand, mice overexpressing PARG had significantly lower infarct volumes. Combined, the current data indicate that PAR is a powerful death signal. What is . . . [Full Text of this Article]